Paycom Software Inc vs Revvity Inc — how do they compare? Paycom Software Inc trades at $232.22 (market cap $10.36B), while Revvity Inc trades at $154.18 (market cap $16.98B). The key difference: Revvity Inc is the larger of the two by market cap, and Paycom Software Inc pays the higher dividend (0.65%). Which is the better fit depends on your goals — on Pluang, investors hold Paycom Software Inc for 84 Days and Revvity Inc for 12 Days on average.
| PAYC | RVTY | |
|---|---|---|
Market Cap | $10.36B | $16.98B |
Volume | 666,294 | 1,456,900 |
Sector | Technology | Health |
52-Week High | $240.52 | $157.36 |
52-Week Low | $113.59 | $82.26 |
Typical Hold Time | 84 Days | 12 Days |
Enterprise Value | $11.15B | $19.30B |
Dividend Yield | 0.65% | 0.18% |
Signals from Pluang's Aura AI — not financial advice
Paycom Software (PAYC) trades at $229.90, up 2.83% today, showing strong momentum after beating Q2 2026 earnings expectations with EPS of $2.78 versus $2.38 expected. The stock demonstrates robust fundamentals with 22.78% net income margin and 41.09% ROE, though valuation metrics like P/E of 24.33 and P/S of 5.6 appear elevated. Technical indicators show bullish momentum with the current price trading above key support levels, while analyst sentiment remains mixed with 47% buy ratings.
PAYC presents a growth opportunity with consistent earnings beats and raised 2026 guidance targeting 7-8% revenue growth, but faces risks from premium valuation and competitive pressures in payroll software. The stock's recent institutional buying activity and strong cash flow generation support the bullish case, though investors should monitor execution against guidance and margin sustainability.
RVTY trades at $152.16, down 0.94% today, near its recent 52-week high of $158.28 (Defense World, 2026-10-01). The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for three consecutive quarters. Recent positive developments include a Zacks upgrade to Buy (2026-10-02) and the launch of a new Type 1 diabetes screening kit in Europe (Business Wire, 2026-09-24).
The outlook is positive, supported by earnings momentum and strategic expansions, but the stock's premium valuation (P/E of 73.15) and margin pressures pose risks. Analyst consensus is bullish with a $132.13 price target, though the current price exceeds it, suggesting near-term consolidation may occur before further gains.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →